Cytyc
This article was originally published in The Gray Sheet
Executive Summary
Subsidiary Cytyc Healthcare Ventures (CHV) is established to "explore and invest in early-stage enterprises in the healthcare industry," the firm announces March 26. Private equity investments made through CHV will focus on those businesses with a strategic fit with Cytyc in the field of cancer diagnostics and women's health, providing "access to new ideas, technologies, and potential partners," Cytyc explains